Dalteparin
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1678 publications
Impact of postoperative weight loss on anticoagulant dosing after major lower limb amputation.
Journal: Annals of the Royal College of Surgeons of England
Published: January 20, 2026
Discovery of a Piperazine-Based Quaternary Ammonium Macrocycle as a Universal Reversal Agent for Heparin Anticoagulants.
Journal: Journal of medicinal chemistry
Published: January 07, 2026
Apixaban Concentrations and Effects on Coagulation in Patients With Nephrotic Syndrome.
Journal: Kidney medicine
Published: December 03, 2025
Clinical use and safety of empiric anticoagulation during diagnostic work-up for deep vein thrombosis.
Journal: Hematology (Amsterdam, Netherlands)
Published: October 21, 2025
Spontaneous inferior epigastric artery hemorrhage in a COVID-19 patient with membranous nephropathy on anticoagulant therapy: a Case Report.
Journal: Frontiers in medicine
Published: October 20, 2025
Intracranial Hemorrhage With Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin in Brain Tumors: A Review and Meta-Analysis.
Journal: Neurology
Published: September 15, 2025
A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study.
Journal: American journal of hematology
Published: July 31, 2025
The win ratio for evaluating edoxaban versus dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai VTE cancer trial.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 18, 2025
HCT-VTE-J Model to Predict Late-Onset Venous Thromboembolism after Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Single-Center Study.
Journal: Transplantation and cellular therapy
Published: July 08, 2025
Last Updated: 02/24/2026